FDA applicant
Eurospital S.P.A.
FDA records 5 decisions for Eurospital S.P.A. (Trieste, IT) from 2000 to 2019: 5 510(k) clearances. Most are in product codes NXO (Calprotectin, Fecal) and LHI (Set, I.V. Fluid Transfer). Its devices cite 4 predicates, 3 of them its own earlier devices. No recall is linked to its devices.
FDA’s records also spell it “Eurospital”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Eurospital S.P.A.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2019
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2007.
Planning a device like Eurospital S.P.A.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report